Skip to main content
Livermore
Livermore
ZHEN

D. E. Shaw & Co., Inc.

SEC CIK
0001009207
Latest filing
Aug 14, 2026

ELV holding history

Elevance Health, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

ELV overviewAll 13F holders of ELVFull Q2 2026 holdings

Shares (Q2 2026)
140,324
Value
$54.3M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of ELV by D. E. Shaw & Co., Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026140,324$54.3M<0.1%−265,668−65.4%ReducedHolders
Q1 2026405,992$118.9M0.1%−86,004−17.5%ReducedHolders
Q4 2025491,996$172.5M0.1%−282,887−36.5%ReducedHolders
Q3 2025774,883$250.4M0.2%+125,879+19.4%AddedHolders
Q2 2025649,004$252.4M0.3%+408,730+170.1%AddedHolders
Q1 2025240,274$104.5M0.1%−465,395−66.0%ReducedHolders
Q4 2024705,669$260.3M0.3%+650,602+1,181.5%AddedHolders
Q3 202455,067$28.6M<0.1%−185,189−77.1%ReducedHolders
Q2 2024240,256$130.2M0.2%−76,657−24.2%ReducedHolders
Q1 2024316,913$164.3M0.2%+52,344+19.8%AddedHolders
Q4 2023264,569$124.8M0.2%−61,560−18.9%ReducedHolders
Q3 2023326,129$142.0M0.2%+21,371+7.0%AddedHolders
Q2 2023304,758$135.4M0.2%+117,491+62.7%AddedHolders
Q1 2023187,267$86.1M0.1%−150,826−44.6%ReducedHolders
Q4 2022338,093$173.4M0.3%+105,776+45.5%AddedHolders
Q3 2022232,317$105.5M0.2%−9,884−4.1%ReducedHolders
Q2 2022242,201$116.9M0.2%+110,242+83.5%AddedHolders
Q1 2022131,959$64.8M0.1%+33,080+33.5%AddedHolders
Q4 202198,879$45.8M0.1%−18,689−15.9%ReducedHolders
Q3 2021117,568$43.8M0.1%+4,295+3.8%AddedHolders
Q2 2021113,273$43.2M<0.1%+74,171+189.7%AddedHolders
Q1 202139,102$14.0M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.